Kaposi’s Sarcoma in an Elderly Man With Wegener’s Granulomatosis Treated With Cyclophosphamide and Corticosteroids

Archives of Internal Medicine

Volumn 148, Issue 5, 1988, Pages 1201-1203

  Erban, Stephen B ^a   Sokas, Rosemary K ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE ACETATE; PREDNISONE;

ADULT; CASE REPORT; HUMAN; KAPOSI SARCOMA; MALE; WEGENER GRANULOMATOSIS;

AGED; CASE REPORT; CYCLOPHOSPHAMIDE; HUMAN; IMMUNOSUPPRESSION; MALE; METHYLPREDNISOLONE; PREDNISONE; SARCOMA, KAPOSI; SKIN NEOPLASMS; WEGENER'S GRANULOMATOSIS;

EID: 0023939902     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1988.00380050205028     Document Type: Article

References (22)

1. 1. Fauci AS, Haynes BF, Katz P, et al: Wegener’s granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98:76-85.
2. 2. Walton EW: Giant-cell granuloma of the respiratory tract (Wegener’s granulomatosis). Br Med J 1958;2:265-270.
3. 3. Klein MB, Pereira FA, Kantor I: Kaposi’s sarcoma complicating systemic lupus erythematosus treated with immunosuppression. Arch Dermatol 1974;110:602-604.
4. 4. Weiss VC, Serushan M: Kaposi’s sarcoma in a patient with dermatomyositis receiving immunosuppressive therapy. Arch Dermatol 1982;118:183-185.
5. 5. Turnbull A, Almeyda J: Idiopathic thrombocytopenic purpura and Kaposi’s sarcoma. Proc R Soc Med 1970;63:603-605.
6. 6. Penn I: The occurrence of malignant tumors in immunosuppressed states. Prog Allergy 1986;37:259-300.
7. 7. Hardy MA, Goldfarb P, Levin S, et al: De novo Kaposi’s sarcoma in renal transplantation. Cancer 1976;38:144-148.
8. 8. Hood AF, Farmer ER, Weiss RA: Kaposi’s sarcoma. Johns Hopkins Med J 1982;151:222-230.
9. 9. Penn I: Kaposi’s sarcoma in organ transplant recipients. Transplantation 1979;27:8-11.
10. 10. Harwood AR, Osoba D, Hofstader SL, et al: Kaposi’s sarcoma in recipients of renal transplants. Am J Med 1979;67:759-765.
11. 11. Gange RW, Jones EW: Kaposi’s sarcoma and immunosuppressive therapy: An appraisal. Clin Exp Dermatol 1978;3:135-146.
12. 12. Hoshaw RA, Schwartz RA: Kaposi’s sarcoma after immunosuppressive therapy with prednisone. Arch Dermatol 1980;116:1280-1282.
13. 13. Scaparro E, Borghi S, Rebora A: Kaposi’s sarcoma after immunosuppressive therapy for bullous pemphigoid. Dermatologica 1984;169:156-159.
14. 14. Schottstaedt MW, Hurd ER, Stone MD: Kaposi’s sarcoma in rheumatoid arthritis. Am J Med 1987;82:1021-1026.
15. 15. Snyder RA, Schwartz RA: Telangiectatic Kaposi’s sarcoma. Arch Dermatol 1982;118:1020-1021.
16. 16. Leung F, Fam AG, Osoba D: Kaposi’s sarcoma complicating corticosteroid therapy for temporal arteritis. Am J Med 1981;71:320-322.
17. 17. Dantzig PI: Kaposi’s sarcoma and polymyositis. Arch Dermatol 1974;110:605-607.
18. 18. Schulhafer EP, Grossman ME, Fagin G, et al: Steroid-induced Kaposi’s sarcoma in a patient with pre-AIDS. Am J Med 1987;82:313-317.
19. 19. Klepp O, Dahl O, Stenwig ST: Association of Kaposi’s sarcoma and prior immunosuppressive therapy. Cancer 1978;42:2626-2630.
20. 20. Penn I: Kaposi’s sarcoma in immunosuppressed patients. J Clin Lab Immunol 1983;12:1-10.
21. 21. Baxter JD: Actions of adrenal steroids, in Cecil’s Textbook of Medicine, ed 17. Philadelphia, WB Saunders Co, 1985, pp 1306-1307.
22. 22. Bast RC, Reinherz EL, Maver C, et al: Contrasting effects of cyclophosphamide and prednisolone on the phenotype of human peripheral blood leukocytes. Clin Immunol Immunopathol 1983;28:101-114.